MRVL · Investment summary · as of 29 July 2026
Priced for an operating path the record does not support
Business type: scaling but economically observable
At $174.36, MRVL requires a 42% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 13%.
The value rests on an exit multiple of 20.0x and a terminal operating margin of 26%. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.
The strongest argument against this view: Scenario: Distributor A's programme volume rolls off, or the custom XPU programme behind it transitions to a competitor at the next node.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | Not determined — the operating driver is not stated in one place |
| What do we forecast? | Revenue growth of 13% demonstrated; a terminal operating margin of 26%; an exit multiple of 20.0x. |
| What does Street forecast? | Not determined — no consensus estimates are joined to this record |
| Where do we differ? | On revenue growth, the difference between what the price requires and what the business has demonstrated is -29.1 percentage points. |
| What is it worth? | Twelve-month target $160.00, -8% from the struck price. Scenario-weighted expected return net of costs -8.2%. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
Not determined — no falsifiable operating conditions are on file for this name, so the thesis cannot be reduced to a small number of testable claims
Date not announced — no dated event that would resolve the disagreement is on file
Scenario: Distributor A's programme volume rolls off, or the custom XPU programme behind it transitions to a competitor at the next node. The specific mechanism, and it has a precedent in this cluster from tonight. Distributor A is 45% of Marvell's revenue, up from 24% two years ago. Three customers hold 75% of gross accounts receivable. Marvell's customers place cancellable purchase orders while Marvell pre-commits foundry capacity up to 52 weeks forward. Custom silicon revenue is programme-shaped: it ramps over a node generation and stops when the customer moves to the next design — which ma
Not determined — no falsifiable invalidation conditions are on file, so this position cannot be risk-monitored
On approach to the $160.00 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Not determined | Is the business worth owning under its declared economic type? Not established on the evidence on file. |
| Valuation | Met | Is the operating path required by today's price achievable? |
| Liquidity | Not determined | Can the intended position be built and exited in the right vehicle? Not established on the evidence on file. |
| Downside | Met | Scenario: Distributor A's programme volume rolls off, or the custom XPU programme behind it transitions to a competitor at the next node. |
| Momentum | Not determined | Does price action support or complicate entry timing? Not established on the evidence on file. |
| Catalyst | Not determined | Is there a dated event that resolves the disagreement? Not established on the evidence on file. |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -29.1 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is whether this is a business worth owning at all — the evidence for its quality is not established. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $130.77, which forces an immediate review.